Editorial

Current Pharmaceutical Design

Volumn 11, Issue 2, 2005, Pages 143-144

  Schechter, Lee E ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; DULOXETINE; FLUOXETINE; HORMONE RECEPTOR BLOCKING AGENT; IMIPRAMINE; IPRONIAZID; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PARGYLINE; PAROXETINE; PHENELZINE; PINDOLOL; SEROTONIN 1A ANTAGONIST; SEROTONIN 2C AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADRENERGIC TRANSMISSION; ANTICHOLINERGIC EFFECT; CARDIOTOXICITY; CLINICAL TRIAL; DRUG DESIGN; DRUG EFFICACY; DRUG MECHANISM; DRUG RESEARCH; DRUG SAFETY; DRUG SELECTIVITY; EDITORIAL; FOOD DRUG INTERACTION; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR DEPRESSION; MOLECULAR DYNAMICS; MONOAMINERGIC SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SEROTONINERGIC TRANSMISSION; SEXUAL DYSFUNCTION; SIDE EFFECT; CLASSIFICATION; PATHOPHYSIOLOGY;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; HUMANS;

EID: 16844368235     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612053382269     Document Type: Editorial

References (5)

1. Malberg JE, Schechter L. Increasing Hippocampal Neurogenesis: A Novel Mechanism for Antidepressant Drugs. Curr Pharm Design 2004; 11(2): 145-155.
2. Crowley JJ, Lucki I. Opportunities to Discover Genes Regulating Depression and Antidepressant Response from Rodent Behavioral Genetics. Curr Pharm Design 2004; 11(2): 157-169.
3. Mitchell PJ, Redfern PH. Animal Models of Depressive Illness: The Importance of Chronic Drug Treatment. Curr Pharm Design 2004; 11(2): 171-203.
4. Ring RH. The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development. Curr Pharm Design 2004; 11(2): 205-225.
5. Demitrack MA. Clinical Perspectives on Antidepressant Drug Development: A Critical Discussion. Curr Pharm Design 2004; 11(2): 227-231.